Ad copy

For decades, surviving sleeping sickness meant undergoing intensive treatment. In the Democratic Republic of Congo — home to the world’s highest burden of gambiense sleeping sickness, or gHAT — patients often faced painful injection-based regimens and significant barriers to accessing care. This film traces the transformation of gHAT treatment, from IV regimens to fexinidazole, the first all-oral therapy, and the promise of acoziborole — a single-dose cure now on the path to approval. Through the voices of researchers, health workers, and global partners, it shows how collaboration and innovation are making elimination possible. 👉 Check the link in our bio to listen to their voices in episode three of Escape the Neglect: Stories from the Front Lines. Produced by Devex in partnership with the @gatesfoundation #EscapetheNeglect #EndNTDs #Community